Actively Recruiting
Peripheral Blood, Urine and Skin Sample Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
Led by University of Pittsburgh · Updated on 2025-12-30
200
Participants Needed
1
Research Sites
104 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are conducting an observational study to collect tissue, urine, and blood samples from patients with cutaneous T-cell lymphoma (CTCL), eczema, and atopic dermatitis. The study aims to support current and future research by providing a central system to monitor access to these biological specimens and to facilitate studies related to immunologic assays, tumor progression, genomic and proteomic analyses, and other research advancing CTCL treatment. Participants with CTCL, Sezary syndrome, atopic dermatitis, or eczema may provide samples including up to nine blood draws per year of 60 ml each and up to four 6 mm skin punch biopsies annually. Urine samples may also be collected as part of the study. These activities help gather important biological material for ongoing and future research projects. During the study, participants will be involved in sample collection procedures such as blood draws, skin biopsies, and urine collection. Researchers will use these samples to study proteomics and other biological markers related to the conditions. The study is ongoing with monitoring to support advancements in understanding and treating CTCL and related skin conditions. Participation involves consenting to provide these specimens and may continue over multiple years as needed for research purposes.
CONDITIONS
Brief Title
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
Who Can Participate
Eligibility Criteria
You may qualify if you...
- 18 years of age or older
- Able and willing to provide informed consent
- Diagnosed with cutaneous T-cell lymphoma (CTCL)
- Diagnosed with atopic dermatitis or eczema
You will not qualify if you...
- No diagnosis of cutaneous T-cell lymphoma, atopic dermatitis, or eczema documented in medical records
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to several years
Participants with cutaneous T-cell lymphoma, atopic dermatitis, or eczema provide blood, urine, and skin samples for research purposes.
Up to 9 blood draws and up to 4 skin biopsies per year
Trial Site Locations
Total: 1 location
1
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, United States, 15213
Actively Recruiting
Research Team
C
Charity L Ruhl, LPN
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here